Undoctored vault view

New Zealand prescribers should be aware of the high risk of death associated with two prescription medicines, methadone and clozapine, University of Otago researchers warn

The Medicines Classification Committee (MCC) has just released the minutes from its October meeting.

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines.

Following Associate Minister of Health Julie Anne Genter’s announcement on 30 October that the way is clear for DHBs to contract pharmacy to vaccinate 16-49 year olds against measles, only 8 of 20 DHBs are now in the process of doing so

The Community Pharmacy Leaders Forum (CPLF), a collaboration of pharmacy organisation leaders with a focus on New Zealand community pharmacies, had a productive meeting this week focussed on developing a unified response to key issues facing community pharmacy.

As many as 12,000 people will get training over the next four years in a major boost for those seeking help for mental health and addiction issues

The "precarious state of New Zealand's public health services" has been laid bare in a new Association of Salaried Medical Specialists (ASMS) report, Hospitals on the Edge. 

Consumer NZ’s latest test of sunscreens found nine of 20 products didn’t provide the sun protection claimed.

AFT Pharmaceuticals today announces it has signed licensing agreements for its Maxigesic pain relief medication in Germany, Pakistan and Vietnam, countries with pain relief markets worth more than US$1 billion.